Research output

Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

Abstract

Ventilator-associated pneumonia (VAP) is a nosocomial infection occurring in the intensive care unit (ICU). The diagnostic standard is based on clinical criteria and bronchoalveolar lavage (BAL). Exhaled breath analysis is a promising non-invasive method for rapid diagnosis of diseases and contains volatile organic compounds (VOCs) that can differentiate diseased from healthy individuals. The aim of this study was to determine whether analysis of VOCs in exhaled breath can be used as a non-invasive monitoring tool for VAP. One hundred critically ill patients with clinical suspicion of VAP underwent BAL. Before BAL, exhaled air samples were collected and analysed by gas chromatography time-of-flight mass spectrometry (GC-tof-MS). The clinical suspicion of VAP was confirmed by BAL diagnostic criteria in 32 patients [VAP(+)] and rejected in 68 patients [VAP(-)]. Multivariate statistical comparison of VOC profiles between VAP(+) and VAP(-) revealed a subset of 12 VOCs that correctly discriminated between those two patient groups with a sensitivity and specificity of 75.8% +/- 13.5% and 73.0% +/- 11.8%, respectively. These results suggest that detection of VAP in ICU patients is possible by examining exhaled breath, enabling a simple, safe and non-invasive approach that could diminish diagnostic burden of VAP.

    Research areas

  • BRONCHOALVEOLAR LAVAGE FLUID, ELECTRONIC-NOSE, METABOLISM, METABOLOMICS, TOOL, ETHYLBENZENE, INFORMATION, RELEVANT, DISEASE, PROTEIN
View graph of relations

Details

Original languageEnglish
Article number17179
Number of pages10
JournalScientific Reports
Volume5
DOIs
Publication statusPublished - 26 Nov 2015